Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
무작위 임상시험
4/5 보강
TL;DR
Quantitative estimation of hair growth using hair weight and number was recorded for 120 weeks in 4 groups of 9 men with androgenetic alopecia, and the 5% and 2% minoxidil treatment groups showed a statistically significant increase in mean percentage change in interval weight from baseline compared with placebo.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
no treatment
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Over 96 weeks, topical minoxidil induced and maintained an increase in interval weight over baseline of about 30%. After treatment was stopped, hair weight and number counts for the minoxidil groups returned to about the same levels as placebo in 24 weeks.
📑 코퍼스 인용 관계
· 인용됨 11
📑 인용한 논문 (6) ▾
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. American journal of clinical dermatology · 2026
- Status of research on the development and regeneration of hair follicles. International journal of medical sciences · 2024
- Combination and Rotational Therapy in Androgenetic Alopecia. Journal of cutaneous and aesthetic surgery · 2023
- Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Futur… Plants (Basel, Switzerland) · 2023
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia a… eLife · 2023
- 3D Spheroid Human Dermal Papilla Cell as an Effective Model for the Screening of Hair Grow… Cells · 2022
연도별 인용 (2012–2026) · 합계 88
OpenAlex 토픽 ·
Hair Growth and Disorders
melanin and skin pigmentation
Skin Protection and Aging
Abstract 🌐 Abstract
Quantitative estimation of hair growth using hair weight and number was recorded for 120 weeks in 4 groups of 9 men with androgenetic alopecia. Three double-blind groups applied either 2% or 5% minoxidil solution, or vehicle. The fourth group, unblinded, received no treatment. Measurements of hair weight and number were continued for 96 weeks, when treatment (if any) was stopped, though measurements were continued for another 24 weeks. Although not compared statistically, the placebo and untreated groups behaved in a similar fashion. In contrast, the 5% and 2% minoxidil treatment groups showed a statistically significant increase in mean percentage change in interval weight from baseline compared with placebo; results for number counts were usually less significant. Over 96 weeks, topical minoxidil induced and maintained an increase in interval weight over baseline of about 30%. After treatment was stopped, hair weight and number counts for the minoxidil groups returned to about the same levels as placebo in 24 weeks.
Quantitative estimation of hair growth using hair weight and number was recorded for 120 weeks in 4 groups of 9 men with androgenetic alopecia, and the 5% and 2% minoxidil treatment groups showed a st
APA 7
Price, V. H., Menefee, E., & Strauss, P. C. (1999). Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.. Journal of the American Academy of Dermatology, 41(5 Pt 1), 717-21. https://doi.org/10.1016/s0190-9622(99)70006-x
Vancouver
Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. Jour. Amer. Acad. Derm.. 1999;41(5 Pt 1):717-21. doi:10.1016/s0190-9622(99)70006-x
AMA 11
Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. Jour. Amer. Acad. Derm.. 1999;41(5 Pt 1):717-21. doi:10.1016/s0190-9622(99)70006-x
Chicago
Price, V. H., Menefee, E., and Strauss, P. C.. 1999. "Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment." Journal of the American Academy of Dermatology 41 (5 Pt 1): 717-21. https://doi.org/10.1016/s0190-9622(99)70006-x
MLA 9
Price, V. H., et al. "Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment." Journal of the American Academy of Dermatology, vol. 41, no. 5 Pt 1, 1999, pp. 717-21. doi:10.1016/s0190-9622(99)70006-x.
PMID
10534633 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 8/8 (100%)
· 참조 0편 · 후속 8편
이 논문을 인용한 후속 연구 11
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considera…
- Minoxidil and its use in hair disorders: a review.
- Androgenetic Alopecia Treatment in Asian Men.
- Status of research on the development and regeneration of hair follicles.
- 3D Spheroid Human Dermal Papilla Cell as an Effective Model for the Screening of Hair Growth Promoti…
- Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Future Perspect…
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata.
- Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the …
- [Minoxidil : From side effects to therapy].
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
- Combination and Rotational Therapy in Androgenetic Alopecia.
같은 제1저자의 인용 많은 논문 (5)
- Treatment of hair loss.
- Androgenetic alopecia in women.
- Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
- Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- COVID-19의 50가지 이상의 장기 후유증: 체계적 문헌고찰 및 메타분석.
- 미국 임상내분비학회, 미국 내분비학회, 안드로겐 과다 및 PCOS 학회 질환 임상 리뷰: 다낭성 난소 증후군의 평가와 치료를 위한 최선의 진료 지침--1부.
- Rochester Epidemiology Project(1990-2009)에서 추정된 원형 탈모의 평생 발병 위험도는 2.1%이다.
- 남성 안드로겐성 탈모.
- 안드로겐성 탈모: 치료 업데이트.
- 원형탈모증 성인 및 청소년 환자에서 ritlecitinib의 유효성과 안전성: 무작위 배정, 이중 맹검, 다기관, 2b-3상 임상시험.